Fda Nod
Sort by
9 items
-
Business - MarketWatch
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.9 hours ago -
Business - MarketWatch
Novavax’s stock slides 19% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 19% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a ...12 hours ago - Covid -
Business - Inc.
FDA Freezes COVID-Flu Combo Vaccine Trial Over Safety Concern
Maker Novavax reported a recipient of the combination vaccine experienced symptoms of nerve cell damage.23 hours ago - FDA -
Business - CNBC
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.Yesterday -
Top stories - NBC News
Maine shooting survivors claim Army negligence and FDA's weight-loss drug decision: Morning Rundown
Detroit, TCF Center, 2024 election, Harris in Pennsylvania, Lewiston Maine shooting, Trump rally shooting survivors, giant pandas at National Zoo, Mount Everest2 days ago -
Business - Financial Times
EU ministers nod to support for nuclear energy ahead of UN climate summit
Bloc officials overcome deep divisions on atomic power but finance goal commitment remains unresolved2 days ago - Climate -
Politics - The Hill
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...3 days ago -
Top stories - NBC News
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.3 days ago